These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


169 related items for PubMed ID: 2784482

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice.
    Moore MA, Warren DJ.
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7134-8. PubMed ID: 3499607
    [Abstract] [Full Text] [Related]

  • 44. Inhibition of the growth of IL-3-dependent mast cells from murine bone marrow by recombinant granulocyte macrophage-colony-stimulating factor.
    Bressler RB, Thompson HL, Keffer JM, Metcalfe DD.
    J Immunol; 1989 Jul 01; 143(1):135-9. PubMed ID: 2471732
    [Abstract] [Full Text] [Related]

  • 45. Recombinant interleukin 3 induces interleukin 2 receptor expression on early myeloid cells in normal human bone marrow.
    Gazzola MV, Collins NH, Tafuri A, Keever CA.
    Exp Hematol; 1992 Feb 01; 20(2):201-8. PubMed ID: 1371965
    [Abstract] [Full Text] [Related]

  • 46. Antitumor protection from the murine T-cell leukemia/lymphoma EL4 by the continuous subcutaneous coadministration of recombinant macrophage-colony stimulating factor and interleukin-2.
    Vallera DA, Taylor PA, Aukerman SL, Blazar BR.
    Cancer Res; 1993 Sep 15; 53(18):4273-80. PubMed ID: 8364923
    [Abstract] [Full Text] [Related]

  • 47. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.
    Schmidt-Wolf IG, Negrin RS, Kiem HP, Blume KG, Weissman IL.
    J Exp Med; 1991 Jul 01; 174(1):139-49. PubMed ID: 1711560
    [Abstract] [Full Text] [Related]

  • 48. Recombinant murine granulocyte-macrophage (GM) colony-stimulating factor supports formation of GM and multipotential blast cell colonies in culture: comparison with the effects of interleukin-3.
    Koike K, Ogawa M, Ihle JN, Miyake T, Shimizu T, Miyajima A, Yokota T, Arai K.
    J Cell Physiol; 1987 Jun 01; 131(3):458-64. PubMed ID: 3298286
    [Abstract] [Full Text] [Related]

  • 49. Anti-tumor cytotoxic potential and effect on human bone marrow GM-CFU of human LAK cells generated in response to various cytokines.
    Parhar RS, Ernst P, Sheth KV, al-Sedairy ST.
    Eur Cytokine Netw; 1992 Jun 01; 3(3):299-306. PubMed ID: 1498260
    [Abstract] [Full Text] [Related]

  • 50. IL-7 stimulates CSF-induced proliferation of murine bone marrow macrophages and Mac-1+ myeloid progenitors in vitro.
    Jacobsen FW, Veiby OP, Jacobsen SE.
    J Immunol; 1994 Jul 01; 153(1):270-6. PubMed ID: 8207241
    [Abstract] [Full Text] [Related]

  • 51. Amplification of IL-2-driven T cell proliferation by recombinant human IL-3 and granulocyte-macrophage colony-stimulating factor.
    Santoli D, Clark SC, Kreider BL, Maslin PA, Rovera G.
    J Immunol; 1988 Jul 15; 141(2):519-26. PubMed ID: 3290340
    [Abstract] [Full Text] [Related]

  • 52. In vitro natural cell-mediated cytotoxicity against Candida albicans: macrophage precursors as effector cells.
    Baccarini M, Bistoni F, Lohmann-Matthes ML.
    J Immunol; 1985 Apr 15; 134(4):2658-65. PubMed ID: 3882833
    [Abstract] [Full Text] [Related]

  • 53. Cytokine expression from bone marrow derived macrophages.
    Temeles DS, McGrath HE, Kittler EL, Shadduck RK, Kister VK, Crittenden RB, Turner BL, Quesenberry PJ.
    Exp Hematol; 1993 Feb 15; 21(2):388-93. PubMed ID: 7678817
    [Abstract] [Full Text] [Related]

  • 54. Production of colony-stimulating factor(s) for granulocyte-macrophage and multipotential (granulocyte/erythroid/megakaryocyte/macrophage) hematopoietic progenitor cells (CFU-GEMM) by clonal lines of human IL-2-dependent T-lymphocytes.
    Greenberger JS, Krensky AM, Messner H, Burakoff SJ, Wandl U, Sakakeeny MA.
    Exp Hematol; 1984 Oct 15; 12(9):720-7. PubMed ID: 6333354
    [Abstract] [Full Text] [Related]

  • 55. Growth of human hemopoietic colonies in response to recombinant gibbon interleukin 3: comparison with human recombinant granulocyte and granulocyte-macrophage colony-stimulating factor.
    Messner HA, Yamasaki K, Jamal N, Minden MM, Yang YC, Wong GG, Clark SC.
    Proc Natl Acad Sci U S A; 1987 Oct 15; 84(19):6765-9. PubMed ID: 3498941
    [Abstract] [Full Text] [Related]

  • 56. Generation of natural killer cells from bone marrow precursors in vitro.
    Kalland T.
    Immunology; 1986 Apr 15; 57(4):493-8. PubMed ID: 3485566
    [Abstract] [Full Text] [Related]

  • 57. Differentiation of NK1.1+, Ly49+ NK cells from flt3+ multipotent marrow progenitor cells.
    Williams NS, Klem J, Puzanov IJ, Sivakumar PV, Bennett M, Kumar V.
    J Immunol; 1999 Sep 01; 163(5):2648-56. PubMed ID: 10453005
    [Abstract] [Full Text] [Related]

  • 58. Proliferative effects of purified granulocyte colony-stimulating factor (G-CSF) on normal mouse hemopoietic cells.
    Metcalf D, Nicola NA.
    J Cell Physiol; 1983 Aug 01; 116(2):198-206. PubMed ID: 6602806
    [Abstract] [Full Text] [Related]

  • 59. Bone marrow natural suppressor cells inhibit the growth of myeloid progenitor cells and the synthesis of colony-stimulating factors.
    Moore SC, Theus SA, Barnett JB, Soderberg LS.
    Exp Hematol; 1992 Nov 01; 20(10):1178-83. PubMed ID: 1426097
    [Abstract] [Full Text] [Related]

  • 60. G-CSF-mobilized CD34+ cells cultured in interleukin-2 and stem cell factor generate a phenotypically novel monocyte.
    Sconocchia G, Fujiwara H, Rezvani K, Keyvanfar K, El Ouriaghli F, Grube M, Melenhorst J, Hensel N, Barrett AJ.
    J Leukoc Biol; 2004 Dec 01; 76(6):1214-9. PubMed ID: 15345723
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.